Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 51
Combinatorial strategies to target RAS-driven cancers
Naiara Perurena, Lisa Situ, Karen Cichowski
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 316-337
Closed Access | Times Cited: 26
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer
Yu Jiang, Yawen Wang, Guofeng Chen, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1806-1822.e11
Open Access | Times Cited: 15
The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation
Lilia Alberghina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15787-15787
Open Access | Times Cited: 32
Reductive stress in cancer: coming out of the shadows
Maolin Ge, Thales Papagiannakopoulos, Liron Bar‐Peled
Trends in cancer (2023) Vol. 10, Iss. 2, pp. 103-112
Closed Access | Times Cited: 23
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
Xinlu Han, Deyu Wang, Yang Liao, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 14
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Metabolic remodeling in cancer and senescence and its therapeutic implications
Yeonju Kim, Yeji Jang, Mi-Sung Kim, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 732-744
Closed Access | Times Cited: 11
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 9
Cancer ENO2 Induces Histone Lactylation-Mediated M2 Macrophage Polarization and Facilitates Metastasis of Head and Neck Squamous Cell Carcinoma
Chenran Wang, Lin Tan, Maohua Huang, et al.
Engineering (2025)
Open Access | Times Cited: 1
Dual-pathway glycolysis inhibition for boosting bioenergetic therapy synergistic with chemodynamic/photothermal therapy
Pengxin Song, Renlu Han, Yun Gao, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149248-149248
Closed Access | Times Cited: 7
Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment
Tingting Zuo, Xiaodie Li, Xuan Ma, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 7
Tumor–Host Cometabolism Collaborates to Shape Cancer Immunity
Yingcheng Wu, Qiang Zou, Peng Jiang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 4, pp. 653-657
Open Access | Times Cited: 7
Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid
Qinghua Wang, Tingting Du, Zhi‐Hui Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4431-4442
Open Access | Times Cited: 7
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna Serganova, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 7
Tumour cell-expressed PD-L1 reprograms lipid metabolism via EGFR/ITGB4/SREBP1c signalling in liver cancer
Man Zhao, Hongfeng Yuan, Guang Yang, et al.
JHEP Reports (2024) Vol. 6, Iss. 4, pp. 101009-101009
Open Access | Times Cited: 6
MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
Elena Richiardone, Rim Al Roumi, Fanny Lardinois, et al.
Cancer Letters (2024) Vol. 598, pp. 217091-217091
Open Access | Times Cited: 6
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Xiaodan Jia, Yue Wang, Yue Qiao, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 6
The role of acetylation and deacetylation in cancer metabolism
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
Clonorchis sinensis Promotes Intrahepatic Cholangiocarcinoma Progression by Activating FASN‐Mediated Fatty Acid Metabolism
Xiaoxue Ren, Yanqing Wu, Tongtong Song, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma
Yan Liao, Junkai Chen, Hao Yao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment
Cheng Cheng, Qingrui Zha, Linmao Sun, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Targeted editing of CCL5 with CRISPR-Cas9 nanoparticles enhances breast cancer immunotherapy
Yan Wei, Shuo Wang, Li Zhu, et al.
APOPTOSIS (2025)
Open Access
Page 1 - Next Page

Scroll to top